-
Teva Pharma Warned By FDA Over Plant Inspection In Jan. 31 Letter, Reported By Bloomberg (TEVA)
Tuesday, May 3, 2011 - 10:30am | 24Teva Pharma (NASDAQ: TEVA) Warned By FDA Over Plant Inspection In Jan. 31 Letter, Reported By Bloomberg
-
Pfizer Says That Gains From Divestitures Will Ultimately Buy Back Shares (PFE)
Tuesday, May 3, 2011 - 10:27am | 21Pfizer (NYSE: PFE) Says That Gains From Divestitures Will Ultimately Buy Back Shares
-
UPDATE: Pfizer Reaffirms FY 2012 Guidance (PFE)
Tuesday, May 3, 2011 - 10:24am | 15UPDATE: Pfizer Reaffirms FY 2012 Guidance (NYSE: PFE)
-
J.P. Morgan Expects Positive FDA Panel For BMTI And Is Raising PT
Tuesday, May 3, 2011 - 9:45am | 127In a recent report, J.P. Morgan expects positive results for BioMimetic Therapeutics ((NASDAQ: BMTI)) at May 12 FDA Panel and has raised the price target on BioMimetic Therapeutics from $16.00 to $17.00. At the FDA Panel on May 12, BMTI is seeking the approval of their Augment bone graft. In the...
-
Citi Gives Its Initial Thoughts On Pfizer Following Recent Earnings Release
Tuesday, May 3, 2011 - 9:44am | 193Pfizer (NYSE: PFE) reported 1Q11 EPS of $0.60, in line with Citi's $0.60 and above the Street's $0.59 on sales of $16.5B vs. Citi's $16.6B & the Street's $16.7B. High than projected gross margins & a lower tax rate largely offset the top-line miss and slightly lower than projected share...
-
Upgrades Downgrades, Stocks to Watch May 3
Tuesday, May 3, 2011 - 8:52am | 279Molycorp, Inc. (MCP) Price target raised to $125 from $85 - Dahlman Rose - 2-3rd tier firm. Up over $1.00 pre mkt with the futures down Arch Coal, Inc (ACI) upgraded hold to buy at Brean Murray - price target raised from $32 to $43 Reasearch in Motion Limited (RIMM) RW Baird lowers them to 41 from...
-
Earnings Roundup For May 3 (PFE, MA, PCS, MYL, WLK, THC, COCO, CTSH, EMR, ADM, LM, IFNNY, TAP, FDP)
Tuesday, May 3, 2011 - 8:33am | 826Pfizer Inc (NYSE: PFE) reported a 10% rise in its first-quarter profit. The company's profit came in at $2.22 billion, or $0.28 per share, versus $2.03 billion, or $0.25 per share, in the year-earlier period. The company's adjusted earnings came in at $0.60 per share. The company's revenue dropped...
-
Pfizer Reports Earnings, Reaffirms Financial Guidance (PFE)
Tuesday, May 3, 2011 - 8:27am | 259Pfizer (NYSE: PFE) reported first-quarter adjusted earnings of $4.8 billion or 60 cents a share, just above the analysts' expectations of 59 cents a share. The adjusted earnings come about from the sale of the Capsugel business and the acquisition of King Pharmaceuticals (NASDAQ: KING). Adjusted...
-
Benzinga's Top Pre-Market NASDAQ Gainers (KLIC, VVUS, ASML, ASMI)
Tuesday, May 3, 2011 - 8:14am | 110Kulicke and Soffa Industries Inc (NASDAQ: KLIC) shares surged 14.62% to $10.35 in the pre-market session. KLIC reported upbeat Q2 results. VIVUS Inc (NASDAQ: VVUS) shares advanced 3.85% to $8.10 in the pre-market session. VVUS posted lower-than-expected Q1 loss. ASML Holding NV (NASDAQ: ASML)...
-
Perrigo Reports Q3 EPS of $1.07 vs. $0.97 Estimate; Net Sales $691.6M vs. $687.93M Estimate (PRGO)
Tuesday, May 3, 2011 - 8:03am | 23Perrigo (NASDAQ: PRGO) Reports Q3 EPS of $1.07 vs. $0.97 Estimate; Net Sales $691.6M vs. $687.93M Estimate
-
Mylan Reports EPS of $0.44 vs. $0.44 Estimate; Revenues $1.45B vs. $1.43B Estimate (MYL)
Tuesday, May 3, 2011 - 7:49am | 21Mylan (NYSE: MYL) Reports EPS of $0.44 vs. $0.44 Estimate; Revenues $1.45B vs. $1.43B Estimate
-
A Peek Into The Market Before The Trading Starts
Tuesday, May 3, 2011 - 7:39am | 405Pre-open movers US stock futures are lower this morning, as investors are awaiting report on factory orders. Futures on the Dow Jones Industrial Average dipped 61 points to 12,703.00 and futures on the S&P 500 stock index fell 7.50 points to 1,350.20. Nasdaq 100 futures dropped 10.50 points to...
-
Jefferies Comments On VIVUS Safety Analysis
Tuesday, May 3, 2011 - 7:36am | 106According to Jefferies, VIVUS (NASDAQ: VVUS) has determined that it is feasible to conduct a retrospective safety analysis (FORTRESS) of commercial topiramate use to rule out risk of birth defects with Qnexa. Jefferies said that VVUS reiterated its refiling guidance of 4Q11. “Although VVUS...
-
Akorn Enters Into an Agreement to Acquire Advanced Vision Research for $26M in Cash (AKRX)
Tuesday, May 3, 2011 - 7:36am | 119Akorn (NASDAQ: AKRX) announced today that it has entered into an agreement to acquire Woburn, MA, based Advanced Vision Research, Inc., a premier over-the-counter ophthalmic company that develops and markets eye care products under the TheraTears® and MacuTrition® brand names, for $26 million in...
-
UPDATE: Pfizer Reports 10% Increase In Q1 Profit
Tuesday, May 3, 2011 - 7:34am | 117Pfizer Inc (NYSE: PFE) reported a 10% rise in its first-quarter profit. The company's profit came in at $2.22 billion, or $0.28 per share, versus $2.03 billion, or $0.25 per share, in the year-earlier period. The company's adjusted earnings came in at $0.60 per share. The company's revenue...